[1]
|
Lederer D J,Martinez F J. Idiopathic Pulmonary Fibrosis[J]. N Engl J Med,2018,378(19):1811-1823. doi: 10.1056/NEJMra1705751
|
[2]
|
Sköld C M,Bendstrup E,Myllärniemi M,et al. Treatment of idiopathic pulmonary fibrosis:A position paper from a nordic expert group[J]. J Intern Med,2017,281(2):149-166. doi: 10.1111/joim.12571
|
[3]
|
Sathiyamoorthy G,Sehgal S,Ashton R W. Pirfenidone and nintedanib for treatment of idiopathic pulmonary fibrosis[J]. South Med J,2017,110(6):393-398. doi: 10.14423/SMJ.0000000000000655
|
[4]
|
张金渝,沈涛,杨维泽,等. 云南道地药材滇龙胆资源调查与评价[J]. 植物遗传资源学报,2012,13(05):890-895. doi: 10.3969/j.issn.1672-1810.2012.05.030
|
[5]
|
潘旭,朱鹤云,张昌浩,等. 龙胆化学成分和药理作用研究进展[J]. 吉林医药学院学报,2020,41(02):150-151.
|
[6]
|
屈朝霞,马朝东,王文林. 苦胆草对斯氏狸殖吸虫致大鼠肝纤维化中TIMP-1表达的影响[J]. 江苏大学学报(医学版),2010,20(05):389-391.
|
[7]
|
王应霞,张丽,张旋,等. 苦胆草对博莱霉素致大鼠肺纤维化的防治作用[J]. 昆明医科大学学报,2016,37(05):38-41. doi: 10.3969/j.issn.1003-4706.2016.05.009
|
[8]
|
Knudsen L,Ruppert C,Ochs M. Tissue remodelling in pulmonary fibrosis[J]. Cell Tissue Res.,2017,367(3):607-626. doi: 10.1007/s00441-016-2543-2
|
[9]
|
Meyer K C. Pulmonary fibrosis,part I:epidemiology,pathogenesis,and diagnosis[J]. Expert Rev Respir Med,2017,11(5):343-359.
|
[10]
|
Lalle G,Twardowski J,Grinberg-Bleyer Y. NF-κB in Cancer Immunity:Friend or Foe[J]. Cells,2021,10(2):355. doi: 10.3390/cells10020355
|
[11]
|
Zhang Q,Lenardo M J,Baltimore D. 30 Years of NF-κB:A Blossoming of Relevance to Human Pathobiology[J]. Cell,2017,168(1-2):37-57. doi: 10.1016/j.cell.2016.12.012
|
[12]
|
Chang X,Zhu A,Liu F,et al. Role of NF-κB activation and Th1/Th2 imbalance in pulmonary toxicity induced by nano NiO[J]. Environ Toxicol,2017,32(4):1354-1362. doi: 10.1002/tox.22329
|
[13]
|
Peng L,Wen L,Shi Q F,et al. Scutellarin ameliorates pulmonary fibrosis through inhibiting NF-κB/NLRP3-mediated epithelial-mesenchymal transition and inflammation[J]. Cell Death Dis,2020,11(11):978. doi: 10.1038/s41419-020-03178-2
|
[14]
|
石勤业,郭剑,徐建红. 核转录因子κB及其抑制因子研究[J]. 医学信息,2020,33(22):45-47. doi: 10.3969/j.issn.1006-1959.2020.22.014
|
[15]
|
王妍妮,王昌明. 肿瘤坏死因子α诱导核转录因子κB信号通路在特发性肺纤维化中的作用机制[J]. 国际呼吸杂志,2014,34(24):1886-1889. doi: 10.3760/cma.j.issn.1673-436X.2014.24.013
|
[16]
|
Ma T,Dong L J,Du X L,et al. Research progress on the role of connective tissue growth factor in fibrosis of diabetic retinopathy[J]. Int J Ophthalmol,2018,11(9):1550-1554.
|
[17]
|
Ramazani Y,Knops N,Elmonem M A,et al. Connective tissue growth factor(CTGF)from basics to clinics[J]. Matrix Biol,2018,69(3):44-66.
|
[18]
|
邹梦林,胡星星,张铭杨,等. ERK1/2信号通过钙蛋白酶调控结缔组织生长因子参与肺纤维化的形成[J]. 武汉大学学报(医学版),2020,41(5):720-724.
|
[19]
|
梁瑞娟. 雾化吸入布地奈德对肺纤维化大鼠肺组织TGF-β和CTGF表达的影响研究[J]. 北方药学,2018,15(3):158-159. doi: 10.3969/j.issn.1672-8351.2018.03.135
|